News RSS Bioethics News.

11/10/2017

Former GSK boss to lead new UK accelerated drug access scheme

External Link - Source: Reuters

Former GlaxoSmithKline boss Andrew Witty is to lead a new British scheme to accelerate access to ground-breaking medicines for conditions such as cancer, dementia and diabetes from April 2018.

This entry was posted in Politics, Research Ethics and tagged , . Bookmark the permalink.